Condition: Ovarian Cancer · Sponsor: National Cancer Center, Korea
Primary stage III-IV epithelial ovarian cancer randomizing between interval cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC)
This description comes directly from the study's public registry record.
Myong Cheol Lim, MD, Ph.D · +820319201760 · gynlim@gmail.com
Always discuss trial participation with your own doctor first.
| Chungnam National University Hospital | Sejong, Chungcheongnam-do, South Korea | Not Yet Recruiting |
| Chungnam National University Sejong Hospital | Sejong, Chungcheongnam-do, South Korea | Not Yet Recruiting |
| Ilsan CHA University Hospital | Goyang-si, Gyeonggi-do, South Korea | Recruiting |
| National Cancer Center | Goyang-si, Gyeonggi-do, South Korea | Recruiting |
| Ajou University Hospital | Suwon, Gyeonggi-do, South Korea | Recruiting |
| Pusan National University Hospital | Pusan, South Korea | Not Yet Recruiting |
| Pusan National University Yangsan Hospital | Pusan, South Korea | Not Yet Recruiting |
| Asan Medical Center | Seoul, South Korea | Not Yet Recruiting |
| Ewha Womans University Mokdong Hospital | Seoul, South Korea | Not Yet Recruiting |
| Severance Hospital | Seoul, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05827523